Looking back on medical devices & supplies - diversified stocks’ Q3 earnings, we examine this quarter’s best and worst ...

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

Abbott Laboratories backed its full-year outlook after posting higher sales in the third quarter, boosted by sales of its nutrition shakes and drinks for adults ...

The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

The court said D.B.'s parents could not meet the threshold for a product liability claim under Louisiana's Products Liability ...

The Abbott Laboratories logo is displayed at the company's booth during the Consumer Electronics Show (CES) on January 5, 2022 in Las Vegas, Nevada. (Photo by Patrick T. FALLON / AFP) (Photo by ...

The fate of hundreds of pending cases against Abbott and Mead Johnson hang in the balance with the latest dismissal.

In 2013, Abbott Labs shifted to focus on generics, medical devices, diagnostics, and nutrition. Since then, it has grown its business and become much more robust and diverse. While it has benefited ...

Abbott Laboratories recently reported fourth-quarter earnings that fell 47% year over year. Declining demand for COVID-19 tests is a challenge, but multiple growth drivers could push the stock higher ...

Abbott Laboratories first quarter profits eclipsed $2.4 billion thanks to a surge in sales of Covid-19 diagnostic tests, the company said April 20, 2022. In this photo, Abbott Chairman of the Board ...